ISBN:
9789048197842
Language:
English
Pages:
Online-Ressource (XI, 228p. 16 illus, digital)
Series Statement:
The International Library of Ethics, Law and Technology 9
Series Statement:
SpringerLink
Series Statement:
Bücher
Parallel Title:
Buchausg. u.d.T. Exploring central and eastern Europe's biotechnology landscape
Keywords:
Biotechnologie
;
Biotechnologie-Industrie
;
Technologiepolitik
;
Osteuropa
;
Philosophy (General)
;
Ethics
;
Biology Philosophy
;
Medical ethics
;
Philosophy
;
Philosophy (General)
;
Ethics
;
Biology Philosophy
;
Medical ethics
;
Biotechnology industries
;
Europe, Central
;
Biotechnology industries
;
Europe, Eastern
;
Science and state
;
Europe, Central
;
Science and state
;
Europe, Eastern
;
Mitteleuropa
;
Biotechnologische Industrie
;
Ethik
;
Recht
;
Verwaltung
;
Osteuropa
;
Mitteleuropa
;
Biotechnologische Industrie
;
Ethik
;
Recht
;
Verwaltung
;
Osteuropa
Abstract:
At a time when the human genome has been sequenced advances in the life sciences seem to have great potential for human health, industry and the environment throughout Central and Eastern Europe (CEE). Still, for some, potential risks and ethical dilemmas remain, surrounding issues such as the appropriate use of GM crops, stem cells, genetic information, the nature of intellectual property and other challenges that come with EU accession. This book is the first of its kind to bring together experts from across Europe to explore the landscape of current life science policy and industrial develo
Description / Table of Contents:
Acknowledgements; Contents; Contributors; 1 Human Life Science and Agricultural Biotechnology in Transition: An Introduction; 1.1 Introduction; 1.2 Scientific Capability Under the Soviet Regime; 1.3 National Science Systems During and After Transition; 1.4 Geo-Political Transformations and European Accession; 1.5 Technological Shifts; 1.6 Contributors to This Volume; 1.7 Conclusion; References; 2 Biotechnology in Central and Eastern Europe: An Overview of Performance and Policy Systems; 2.1 Introduction; 2.2 Methodology; 2.3 Performance in Biotechnology
Description / Table of Contents:
2.4 CEE Countries' Policy-Making Systems2.4.1 General Characteristics; 2.4.2 Science and Technology Policy Actors; 2.5 Funding of Biotechnology; 2.6 Policy Characteristics Supporting Biotechnology Development; References; 3 Citizen Participation in Controversial EU Research Policies? The Debate on Human Embryonic Stem Cell Research Within the 6th Framework Programme; 3.1 Introduction; 3.2 Decision-Making; 3.2.1 The European Commission; 3.2.2 The European Council; 3.2.3 The European Parliament; 3.3 How "Participatory" Was Decision-Making?; 3.3.1 Process of Decision-Making
Description / Table of Contents:
3.3.2 How Does the Commission Handle the Challenging Problem of HESC?3.3.2.1 The European Group on Ethics in Science and New Technologies (EGE); 3.3.2.2 European Group on Life Science (EGLS); 3.3.3 Informing the Public Directly and Indirectly; 3.4 Summary; References; 4 The Politics of Human Embryo Research in Poland; 4.1 Introduction; 4.2 Obscured Policy Regulations; 4.3 The Public Sphere and "Public Morals"; 4.4 A Limited Policy-Making Capacity; 4.5 Life for Life -- Public Consultation on Human Stem Cell Research; 4.6 Conclusion and Outlook; References
Description / Table of Contents:
5 Legal Ambiguities Concerning Medical Genetics in Poland -- Searching For a Common Ground5.1 Introduction; 5.2 International Legal Framework; 5.3 Genetic Research; 5.3.1 Genetic Research as Research Involving Human Subjects; 5.3.1.1 Setting the Scene; 5.3.1.2 Types of Medical Experiments with Human Subjects; 5.3.1.3 Informed Consent; 5.3.2 Research on Biological (Genetic) Material and Data; 5.3.2.1 Rules Concerning the Use of Biological Material; 5.3.2.2 Rules Concerning the Use of Biological/Health Data; 5.4 Medical Practice; 5.4.1 Genetic Testing as Processing of Biological (Genetic) Data
Description / Table of Contents:
5.4.2 The Right to Know and the Right Not to Know5.4.3 Genetic Tests Available 'Over the Counter'; 5.4.4 Genetic Prenatal and Pre-implantation Diagnosis; 5.5 Conclusions; References; 6 Managing Trust and Risk in New Biotechnologies: The Case of Population Genome Project and Organ Transplantation in Latvia; 6.1 Introduction; 6.2 Positioning the Technologies; 6.3 Methods; 6.4 Biotechnologies and Risks; 6.5 Risks Produced by Technology: Living Without It; 6.6 Risks Applying Technology: Individual and Collective; 6.7 Using Risks in Reconceptualizing Illness
Description / Table of Contents:
6.8 Trust in Abstract Tokens -- Reputation of Science and Medicine
Note:
Description based upon print version of record
DOI:
10.1007/978-90-481-9784-2
URL:
Volltext
(lizenzpflichtig)
Permalink